Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POTENT Study: Intranasal Povidone Iodine to Prevent SSI in Lower Extremity Fractures
NCT05763602Phase 4Active, not recruiting
- Sponsor
- Loreen Herwaldt
- Start
- Sep 2022
- Primary completion
- May 2026
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of IVIEW-1502 in surgical site infection (SSI), sponsored by Loreen Herwaldt. Started Sep 2022; status: active, not recruiting.
02
Drugs
IVIEW-1502
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05763602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05763602.